Common use of CREATE Act Clause in Contracts

CREATE Act. It is the Parties’ intention that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products under such safe harbor provisions.

CREATE Act. It is the Parties’ intention that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds Licensed ARCUS Nuclease and Licensed Products under such safe harbor provisions.

CREATE Act. It is the Parties’ intention The Parties intend that this Agreement is a “joint research agreement” as that phrase is defined in . The Parties further agree to cooperate and to take reasonable actions to maximize the protections available for any Inventions under the safe harbor provisions of 35 U.S.C. § §102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products under such safe harbor provisions.§102(b)(2)(c).21 35 USC 102(c) - Common

CREATE Act. It is the Parties’ intention that this This Agreement is partially a “"joint research agreement” " between the parties, as that phrase is defined in the CREATE Act, 35 U.S.C. § 102(c) Section 103(c), under which the Parties will carry out some of their obligations pursuant to paragraph 2. Intellectual Property developed as amended by a result of any Program will be deemed to have been made as a result of activities undertaken within the Cooperative Research scope of the joint research agreement and Technology Enhancement (CREATE) subject to the CREATE Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products under such safe harbor provisions.

CREATE Act. It is the Parties’ intention of the Parties that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § §102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § §102(b)(2)(c). The , and the Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds Licensed Patents, Joint Patents, Kineta Sole Patents and Products under such safe harbor provisionsAssigned Joint Study Patents.

CREATE Act. It is the Parties’ intention The Parties acknowledge and agree that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) ActAct of 2004, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products under such safe harbor provisionsU.S. Public Law 108-453.

CREATE Act. It is the Parties’ intention that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds Licensed ARCUS Nucleases and Licensed Products under such safe harbor provisions.

CREATE Act. It is the Parties’ intention that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § 100(h). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Licensed ARCUS Nucleases and Licensed Products under 35 U.S.C. § 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products under such safe harbor provisions.

CREATE Act. It is the Parties’ intention of the Parties that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § §102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § §102(b)(2)(c). The , and the Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products Licensed Technology under such safe harbor provisions.

CREATE Act. It is the Parties’ intention that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § §102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § §102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Products Patent Rights covering the Licensed Technology, Future Oncology Technology or Future Non-Oncology Technology under such safe harbor provisions.

CREATE Act. It is the Parties’ intention that this Agreement is a “joint research agreement” as that phrase is defined in 35 U.S.C. § 102(c) as amended by the Cooperative Research and Technology Enhancement (CREATE) Act, including the provisions of 35 U.S.C. § 102(b)(2)(c). The Parties agree to cooperate and to take reasonable actions to maximize the protections available for the Compounds and Licensed Products under such safe harbor provisions.